Motor
Sydenham Chorea
search
Sydenham Chorea
, Sydenham's Chorea, Rheumatic Chorea, Saint Vitus Dance
See Also
Group A Beta Hemolytic
Streptococcus
Rheumatic Fever
PANDAS
Pathophysiology
Childhood
Movement Disorder
Occurs within 8 months of Streptococcal infection
Specifically Group A Beta Hemolytic
Streptococcus
Late manifestation of
Rheumatic Fever
Epidemiology
Incidence
: <5% of
Rheumatic Fever
cases
Ages: 5 to 15 years
Girls affected more often than boys
Symptoms
Gradual onset of neurological symptoms
Atypical behavior
Irritability and crying
Anxiety and restlessness
Transient
Acute Psychosis
Poor memory retention
Motor weakness
Abrupt onset of choreoform movements (purposeless, nonrhythmic, involuntary) only present while awake
Irregular and aimless
Affects extremities, face and trunk
Signs
Choreiform
movements
Abrupt, purposeless, nonrhythmic involuntary movement
Hyperextended joints
Motor weakness
Inaccurate voluntary motions
Clumsiness
Hypotonia
Diminished
Deep Tendon Reflex
es
Speech
Impairment
(
Dysarthria
)
Asymmetric (one side usually more affected than other)
Labs
Strep Test or
Throat Culture
Negative in >50% of cases
Cerebrospinal fluid
Intracerebral pressure (opening pressure) increased
CSF Glucose
increased
CSF Leukocyte
count increased
Late manifestation results in negative markers
ASO Titer
negative
Acute phase reactants negative
Management
Evaluate for other manifestations of
Rheumatic Heart Disease
Initiate
Penicillin
Initial Treatment (often given regardless of
Throat Culture
result)
See
Streptococcal Pharyngitis
Secondary Prophylaxis
Medications
Penicillin G
1.2 million units IM every 21 days
Duration
No Carditis: Administer for at least 5 years AND until age >18 years
Mild Carditis: Administer for at least 10 years AND until age >21 years
Moderate to severe carditis: Lifelong
Penicillin
prophylaxis
Mild to no functional
Impairment
No
Chorea
treatment needed
Moderate to severe
Impairment
Step 1a: Anticonvulsant (choose one)
Valproate
20 mg/kg/day OR
Carbamazepine
15 mg/kg/day
Step 1b: Adjunctive
Corticosteroid
s (Indicated in severe or refractory cases,
Chorea
paralytica)
Prednisone
2 mg/kg/day for 2-4 weeks, followed by taper OR
Methylprednisolone
25 mg/kg/day IV for 5 days, followed by taper
Step 2: Reevaluate response to anticonvulsants
Improved: Wean as tolerated after 4 weeks symptom free
Refractory: Go to Step 3
Step 3: Refractory Management
Add
Antipsychotic
(choose 1)
Risperidone
1-2 mg orally twice daily (teen 0.5 mg twice daily in age 13-17 years) OR
Olanzapine
5-10 mg/day orally (teen 2.5 to 5 mg/day in age 13 to 17 years) OR
Haloperidol
5-10 mg orally every 6-8 hours (child 0.05 to 0.15 mg/kg up to 2-5 mg for teen) OR
Pimozide
1-2 mg at bedtime (child 0.05 mg/kg up to 1 to 2 mg)
Persistent refractory symptoms despite
Antipsychotic
and anticonvulsant
Consider
Corticosteroid
s (see Step 1b above)
Consider experimental treatments
IVIG 2 g/kg IV for 5 days
Plasmapheresis
for 5 days
Prognosis
Self limited
Expect improvement within 3 to 6 weeks (complete resolution by 2-3 years)
Reference
Dean (2017) Tremor Other Hyperkinet Mov 7:456 +PMID: 28589057 [PubMed]
Swedo (1993) Pediatrics 91(4): 706-13 [PubMed]
Type your search phrase here